FDA PROPOSALS TO PERMIT THE USE OF DISEASESPECIFIC HEALTH CLAIMS ON FOOD LABELS HEARING BEFORE A SUBCOMMITTEE OF THE GOVERNMENT OPERATIONS HOUSE OF REPRESENTATIVES ONE HUNDREDTH CONGRESS FIRST SESSION DECEMBER 10, 1987 Printed for the use of the Committee on Government Operations 83-531 U.S. GOVERNMENT PRINTING OFFICE WASHINGTON 1988 For sale by the Superintendent of Documents, Congressional Sales Office COMMITTEE ON GOVERNMENT OPERATIONS JACK BROOKS, Texas, Chairman JOHN CONYERS, JR., Michigan STEPHEN L. NEAL, North Carolina ROBERT E. WISE, JR., West Virginia BEN ERDREICH, Alabama GERALD D. KLECZKA, Wisconsin MATTHEW G. MARTINEZ, California LOUISE M. SLAUGHTER, New York BILL GRANT, Florida NANCY PELOSI, California FRANK HORTON, New York HOWARD C. NIELSON, Utah JOSEPH J. DIOGUARDI, New York JIM LIGHTFOOT, Iowa DONALD E. "BUZ" LUKENS, Ohio JAMES M. INHOFE, Oklahoma CONTENTS Barness, Lewis, M.D., representing the American Academy of Pediatrics... Shils, Maurice E., M.D., representing the New York Academy of Medicine Swan, Patricia B., Ph.D., American Institute of Nutrition/American Soci- ety for Clinical Nutrition...... Weiss, Hon. Ted, a Representative in Congress from the State of New York, and chairman, Human Resources and Intergovernmental Rela- tions Subcommittee: Opening statement Young, Frank E., M.D., Commissioner, Food and Drug Administration, accompanied by John M. Taylor, Associate Commissioner for Regula- tory Affairs; Richard J. Ronk, Acting Director, Center for Food Safety and Applied Nutrition (CFSAN); Allan L. Forbes, M.D., Director, Office of Nutrition and Food Sciences, CFSAN; Thomas Scarlett, Associate General Counsel, Food and Drug Division, Office of the General Coun- sel; Mary Frances Lowe, Senior Assistant to the Commissioner for Program Policy, Office of the Commissioner; F. Edward Scarbrough, Deputy Director, Office of Nutrition and Food Sciences, CFSAN; John E. Vanderveen, Director, Division of Nutrition, Office of Nutrition and Food Sciences, CFSAN; Paul J. Sage, Office of Compliance, Center for Drug Evaluation and Research; and Fred H. Degnan, Food and Drug (III) |